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Figure S1. Analysis of Suppressors of the Gtr1S20L-Mediated Growth Inhibition, Related to Table 1 
(A) Complementation analysis of the mutations (see Table 1) that suppress the Gtr1S20L-mediated growth 
inhibition. The ability of the indicated double mutants to grow when Gtr1S20L was overproduced from the 
galactose-inducible GAL1 promoter was analyzed in the absence (empty plasmid control; + C) and presence (+ 
GENE) of the respective indicated (plasmid-expressed) wild-type genes after cells were spotted (10-fold serial 
dilutions) and grown for 3 days at 30°C on galactose (Gal). 
(B) To independently confirm the results from our selection for mutations that suppress the growth inhibition of 
overproduced Gtr1S20L, the respective genes were deleted in a gtr1Δ background. Strains were analyzed as in 
(A). 
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Figure S2. Construction of a Functional Pib2200-GFP, Related to Figures 2J-L 
(A) Schematic depiction of GFP integration sites in Pib2. The positions for the integration of GFP were chosen 
so that they would not interfere with the FYVE domain, the C-terminal tail motif, or with any region with a 
potential secondary structure according to Jpred 4 (http://www.compbio.dundee.ac.uk/jpred/). For further 
details, see also (Kim and Cunningham, 2015; Michel et al., 2017). Of note, our attempt to fuse GFP at either N- 
or C-terminus of Pib2 ended up with impairing its function (data not shown). 
(B, C) Strains expressing genomically-tagged Pib2200-GFP (B) and Pib2200-mCherry (C) are fully functional, 
while Pib2610-GFP is partially functional with respect to rapamycin sensitivity. Indicated strains were streaked 
and grown for 3 days on YPD plates containing, or not (control), indicated concentrations of rapamycin. 
(D) Pib2200-GFP and Pib2610-GFP normally mediate TORC1 activation by glutamine. Indicated strains were 
grown to mid-log phase in SD-proline medium (-) and stimulated with 3 mM glutamine for 2 minutes (+). 
TORC1 activity was assessed as in Figure 3C. 
(E, F) GFP-Tor1 colocalizes with Vps27-mCherry in WT and ego1Δ cells (E), and Pib2200-GFP colocalizes with 
FM4-64 in WT and gga1Δ gga2Δ cells, but only assembles on endosomes in WT cells (F). See also Figure 2. 
Scale bars, 5 µm (white). 
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Figure S3. Vph1 is Essential to Ensure Vacuolar TORC1 Activity and Artificial Tethering of mCherry-
Tor1I1954V to Endosomes Depletes Vacuolar TORC1 Activity, Related to Figures 4A and 4E 
(A) Loss of Vph1 abolishes the glutamine-stimulated phosphorylation of the vacuolar TORC1 reporter, but only 
mildly affects the respective phosphorylation of the endosomal TORC1 reporter. Indicated dilutions of the WT 
sample were compared to 100% of the vph1Δ sample (both from Figure 4A), this latter serving as a reference of 
endosomal reporter (ET) phosphorylation in response to 3 mM glutamine stimulation. Similar signal intensity 
was obtained with 70% of the WT sample (compare ET phosphorylation in lanes 2 and 8), indicating that loss of 
Vph1 slightly compromises endosomal TORC1. Remarkably, in these same samples, phosphorylation of the 
vacuolar reporter (VT) was not detected in vph1Δ even after prolonged exposure of the immunoblots (compare 
VT phosphorylation in lanes 2 and 8), indicating that Vph1 is specifically required for glutamine-triggered 
vacuolar TORC1 activation. 
(B) mCherry-Tor1I1954V mediates phosphorylation of both endosomal and vacuolar TORC1 reporters, while its 
artificial hooking to endosomes (through a fusion with a FYVE domain) specifically impairs its ability to 
phosphorylate the vacuolar reporter in glutamine-stimulated cells. tor1Δ cells expressing mCherry-Tor1I1954V 
(Control; C) or FYVE-mCherry-Tor1I1954V (FYVE; F) were grown as in Figure 4E, and stimulated with 
increasing concentrations of glutamine for 2 min. Upon stimulation with 3 mM glutamine, both constructs 
similarly triggered maximal phosphorylation of the endosomal reporter (ET), while endosome-targeted FYVE-
mCherry-Tor1I1954V failed to phosphorylate the vacuolar reporter (VT). Of note, only FYVE-mCherry-Tor1I1954V 
sustained, as expected, ET phosphorylation after stimulation (or not) with very low levels of glutamine (i.e. < 5 
µM).  
 
WT YSK¨
- + +- +- +-Gln
anti-
Sch9-
pThr737
ET
VT
*
-
-
anti-
GFP
ET
VT
-
-
10070 50 30% loaded
A
B
anti-
Sch9-
pThr737
ET
VT
*
-
-
short
exposure
long
exposure
anti-
GFP
ET
VT
-
-
anti-
Sch9-
pThr737
ET
VT
*
-
-
WRU¨)<9(P&KHUU\725,9(F) or P&KHUU\725,9(C) 
Pro
 -> Gln
(μM)
F C F C F C F C F C F C
0 4.8 24 120 600 3000
 - 4 - 
 
Figure S4. SILAC-Based Quantification of TORC1-Responsive Vps27 Phosphosites In Vivo, Related to 
Figure 5C 
Bar diagram lists the phosphosites identified on purified Vps27 comparing SILAC labeled cycloheximide 
treated to untreated control cells. *: sites identified as increased by a minimum of 80% (average value, n = 2). 
 
 
 
 
Figure S5. TORC1 Impinges on Vps27 to Inhibit ESCRT-Driven Degradation of Vacuolar Membrane-
Resident GFP-Pho8, Related to Figure 5F 
Cells expressing, or not (-), indicated Vps27 alleles from plasmids were grown exponentially (-) and then treated 
with rapamycin (200 ng ml-1; +) for 4 hours. Corresponding cell extracts were subjected to immunoblot analyses 
using anti-GFP antibodies to measure the levels of GFP-cleavage from plasmid-expressed GFP-Pho8. The 
levels of Vps27 variants were analyzed by immunoblot analysis using anti-Vps27 antibodies. 
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Table S1. TORC1-Controlled Phosphorylation Sites in Vps27a, Related to Figure 5A 
Peptide Positions PEP Score Phospho-Ser/Thr Probabilities 
P1-Vps27-Sc 159 5.2E-110 115 LTLS(0.008)NS(0.024)PT(0.966)AMFDS(0.002)K 
P2-Vps27-Sc 274 0.0014 62 AIELS(0.01)LKES(0.99)R 
P3-Vps27-Sc 279 5.8E-56 88 NS(0.013)AS(0.929)S(0.058)EPIVPVVESK 
P3-Vps27-Sc 280 8.6E-23 69 NS(0.001)AS(0.088)S(0.911)EPIVPVVESK 
P1-Vps27-Ec 155 1.38E-10 117 LTLS(0.994)NS(0.006)PTAMFDSK 
P1-Vps27-Ec 157 < 4.0E-128 362 LTLSNS(1)PTAMFDSK 
P2-Vps27-Ec 274 0.0007 125 AIELSLKES(1)R 
P3-Vps27-Ec 277 1.3E-38 165 NS(1)ASSEPIVPVVESK 
P3-Vps27-Ec 280 4.0E-128 218 NSASS(1)EPIVPVVESK 
P4-Vps27-Ec 339 1.1E-08 72 QMQPQQPS(1)PQPQPIHSVDLSDEEK 
P5-Vps27-Ec 495 8.9E-37 161 ANS(0.003)S(0.997)PTTNIDHLK 
aVps27 isolated from S. cerevisiae (Vps27-Sc) or codon-optimized Vps27 (coexpressed with Hse1) isolated 
from E. coli (Vps27-Ec) were phosphorylated by TORC1 in vitro. Subsequent MS-analysis allowed the 
identification of the same 3 phosphopeptides (P1-3) in Vps27-Sc (green shading) and in Vps27-Ec (blue 
shading) and two additional ones in Vps27-Ec (P4/5; blue shading). The phospho-Ser/Thr localization 
probabilities indicate the positions of the most likely phosphorylated amino acid residues. Sites marked in blue 
and the ones marked in yellow (i.e. Thr159 and Ser279 that were identified as potential TORC1 target sites in 
Vps27-Sc [phospho-Ser/Thr probability > 0.9]) were exchanged to alanines to create the Vps2710A for the in 
vitro TORC1 kinase assay in Figure 5B. The sites marked in red were exchanged to phospho-mimetic aspartates 
to create Vps277D for in vivo studies in yeast. PEP: posterior error probability; Score: Andromeda score. 
